Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACA | Q13085 | 4/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.48 |
| ▸ | DHODH | Q02127 | 1/20 | 0.47 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | DHFR | P00374 | 1/20 | 0.45 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29662015 | 1.00 | ACACA (0.50) | ACACAHSP90AA1SMN1; SMN2LMNAKDM4E | |
| SCHEMBL28204601 | 0.91 | ACACA (0.45) | ACACAHSP90AA1SMN1; SMN2LMNAKDM4E | |
| SCHEMBL28290618 | 0.89 | PDE10A (0.45) | ACACAHSP90AA1SMN1; SMN2LMNAKDM4E | |
| SCHEMBL13458966 | 0.88 | SMN1; SMN2 (0.54) | ACACASMN1; SMN2LMNAKDM4EALDH1A1 | |
| SCHEMBL13458686 | 0.83 | MEN1 (0.56) | ACACASMN1; SMN2LMNAKDM4EALDH1A1 | |
| SCHEMBL440405 | 0.81 | MEN1 (0.40) | ACACASMN1; SMN2LMNAKDM4EALDH1A1 | |
| SCHEMBL13458669 | 0.79 | ACACA (0.66) | ACACASMN1; SMN2LMNAKDM4EALDH1A1 | |
| SCHEMBL1228342 | 0.79 | ENPP3 (0.45) | ACACASMN1; SMN2LMNAKDM4EALDH1A1 | |
| SCHEMBL13458754 | 0.79 | ACACA (0.50) | ACACASMN1; SMN2LMNAKDM4EALDH1A1 | |
| SCHEMBL13458947 | 0.78 | ACACA (0.41) | ACACASMN1; SMN2LMNAKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240298524-A1 | N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant | NOVALED GMBH (DE) | 2024-09-05 | — | — | US | claimed |
| US-11355721-B2 | Organic light emitting device comprising polar matrix, metal dopant and silver cathode | NOVALED GMBH (DE) | 2022-06-07 | — | — | US | claimed |
| US-20210202842-A1 | N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant | NOVALED GMBH (DE) | 2021-07-01 | — | — | US | claimed |
| EP-3109919-B1 | N-DOPED SEMICONDUCTING MATERIAL COMPRISING POLAR MATRIX AND METAL DOPANT | NOVALED GMBH (DE) | 2021-06-23 | — | — | EP | claimed |
| US-10749115-B2 | N-doped semiconducting material comprising polar matrix and metal dopant | NOVALED GMBH (DE) | 2020-08-18 | — | — | US | claimed |
| EP-3087621-B1 | N-DOPED SEMICONDUCTING MATERIAL COMPRISING PHOSPHINE OXIDE MATRIX AND METAL DOPANT | NOVALED GMBH (DE) | 2019-04-17 | — | — | EP | claimed |
| US-20190036032-A1 | N-Doped Semiconducting Material Comprising Polar Matrix and Metal Dopant | NOVALED GMBH (DE) | 2019-01-31 | — | — | US | claimed |
| US-20180190922-A1 | Organic Light Emitting Device Comprising Polar Matrix, Metal Dopant and Silver Cathode | NOVALED GMBH (DE) | 2018-07-05 | — | — | US | claimed |
| EP-3312899-A1 | ELECTRON TRANSPORT LAYER STACK FOR AN ORGANIC LIGHT-EMITTING DIODE | Novaled GmbH (DE) | 2018-04-25 | — | — | EP | claimed |
| EP-2887416-B1 | N-doped semiconducting material comprising phosphine oxide matrix and metal dopant | NOVALED GMBH (DE) | 2018-02-21 | — | — | EP | claimed |
| EP-3109916-A1 | ORGANIC LIGHT EMITTING DEVICE COMPRISING POLAR MATRIX, METAL DOPANT AND SILVER CATHODE | Novaled GmbH (DE) | 2016-12-28 | — | — | EP | claimed |
| EP-3109919-A1 | N-DOPED SEMICONDUCTING MATERIAL COMPRISING POLAR MATRIX AND METAL DOPANT | Novaled GmbH (DE) | 2016-12-28 | — | — | EP | claimed |
| US-20160322568-A1 | N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant | NOVALED GMBH (DE) | 2016-11-03 | — | — | US | claimed |
| EP-3087621-A1 | N-DOPED SEMICONDUCTING MATERIAL COMPRISING PHOSPHINE OXIDE MATRIX AND METAL DOPANT | Novaled GmbH (DE) | 2016-11-02 | — | — | EP | claimed |
| EP-1499624-B1 | ELECTROLUMINESCENT MATERIALS | UNIV HONG KONG (CN) | 2016-01-06 | — | — | EP | claimed |
| EP-2887416-A1 | N-doped semiconducting material comprising phosphine oxide matrix and metal dopant | Novaled GmbH (DE) | 2015-06-24 | — | — | EP | claimed |
| US-12492168-B2 | Organic material for an electronic optoelectronic device and electronic device comprising the organic material | NOVALED GMBH (DE) | 2025-12-09 | — | — | US | disclosed |
| US-20240298524-A1 | N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant | NOVALED GMBH (DE) | 2024-09-05 | — | — | US | disclosed |
| US-6653654-B1 | Light emitting diodes having electrodes, charge tranfer compounds, emitter layers comprising mixtures of beryllium bis(2-(2'-hydroxyphenyl)pyridine) and platinum complexes as dopes; brightness; heat resistance | THE UNIVERSITY OF HONG KONG (CN) | 2003-11-25 | — | — | US | disclosed |
| US-20030205707-A1 | ELECTROLUMINESCENT MATERIALS | VERSITECH LIMITED (HK) | 2003-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12492168-B2 | Organic material for an electronic optoelectronic device and electronic device comprising the organic material | OCIAD1, OCIAD2, OR10J3 | ACACA 2559/4885HSP90AA1 4725/4885SMN1; SMN2 4561/4885 |
| US-20160322568-A1 | N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant | NNMT, PNN, PNMT | ACACA 4283/4885HSP90AA1 3932/4885SMN1; SMN2 1610/4885 |
| US-20240298524-A1 | N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant | NNMT, PNN, PNMT | ACACA 4283/4885HSP90AA1 3932/4885SMN1; SMN2 1610/4885 |
| US-20210202842-A1 | N-Doped Semiconducting Material Comprising Phosphine Oxide Matrix and Metal Dopant | NNMT, PNN, PNMT | ACACA 4283/4885HSP90AA1 3932/4885SMN1; SMN2 1610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.